278 related articles for article (PubMed ID: 16680126)
1. Building biomanufacturing capacity--the chapter and verse.
Kamarck ME
Nat Biotechnol; 2006 May; 24(5):503-5. PubMed ID: 16680126
[TBL] [Abstract][Full Text] [Related]
2. Medium term planning of biopharmaceutical manufacture using mathematical programming.
Lakhdar K; Zhou Y; Savery J; Titchener-Hooker NJ; Papageorgiou LG
Biotechnol Prog; 2005; 21(5):1478-89. PubMed ID: 16209554
[TBL] [Abstract][Full Text] [Related]
3. Screening for drug discovery: the leading question.
Smith A
Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
[No Abstract] [Full Text] [Related]
4. The state of biopharmaceutical manufacturing.
Molowa DT; Mazanet R
Biotechnol Annu Rev; 2003; 9():285-302. PubMed ID: 14650933
[TBL] [Abstract][Full Text] [Related]
5. An interview with Peter J. Coassin. Interview by Vicki Glaser.
Coassin PJ
Assay Drug Dev Technol; 2005 Apr; 3(2):125-31. PubMed ID: 15871687
[No Abstract] [Full Text] [Related]
6. Masters of efficiency.
Hoag H
Nat Biotechnol; 2007 Jan; 25(1):139-40. PubMed ID: 17211408
[TBL] [Abstract][Full Text] [Related]
7. Multiobjective long-term planning of biopharmaceutical manufacturing facilities.
Lakhdar K; Savery J; Papageorgiou LG; Farid SS
Biotechnol Prog; 2007; 23(6):1383-93. PubMed ID: 17924645
[TBL] [Abstract][Full Text] [Related]
8. Biomanufacturing, from bust to boom...to bubble?
Thiel KA
Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
[No Abstract] [Full Text] [Related]
9. Medium term planning of biopharmaceutical manufacture with uncertain fermentation titers.
Lakhdar K; Farid SS; Titchener-Hooker NJ; Papageorgiou LG
Biotechnol Prog; 2006; 22(6):1630-6. PubMed ID: 17137311
[TBL] [Abstract][Full Text] [Related]
10. Flexibility--the guiding principle for antibody manufacturing.
Carson KL
Nat Biotechnol; 2005 Sep; 23(9):1054-8. PubMed ID: 16151390
[TBL] [Abstract][Full Text] [Related]
11. Mammalian cell culture capacity for biopharmaceutical manufacturing.
Ecker DM; Ransohoff TC
Adv Biochem Eng Biotechnol; 2014; 139():185-225. PubMed ID: 23748352
[TBL] [Abstract][Full Text] [Related]
12. Helping secure the global pharmaceutical manufacturing supply chain.
Lawson M
Drug Discov Today; 2009 Jun; 14(11-12):533-5. PubMed ID: 19487154
[No Abstract] [Full Text] [Related]
13. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
Närhi M; Nordström K
Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720
[TBL] [Abstract][Full Text] [Related]
14. Trends in capacity utilization for therapeutic monoclonal antibody production.
Langer ES
MAbs; 2009; 1(2):151-6. PubMed ID: 20061821
[TBL] [Abstract][Full Text] [Related]
15. Extractables from integrated single-use systems in biopharmaceutical manufacturing. Part I. Study on components (Pall Kleenpak connector and Kleenpak filter capsule).
Ding W; Nash R
PDA J Pharm Sci Technol; 2009; 63(4):322-38. PubMed ID: 20088246
[TBL] [Abstract][Full Text] [Related]
16. Bioanalysis: challenges and solutions seminar.
Roberts A
Bioanalysis; 2011 Sep; 3(17):1905-6. PubMed ID: 21899500
[TBL] [Abstract][Full Text] [Related]
17. Evolution and future of biopharmaceuticals.
Health Aff (Millwood); 2006; 25(5):1270. PubMed ID: 16966722
[No Abstract] [Full Text] [Related]
18. Gene therapy: cursed or inching towards credibility?
Branca MA
Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060
[No Abstract] [Full Text] [Related]
19. Application of a decision-support tool to assess pooling strategies in perfusion culture processes under uncertainty.
Lim AC; Zhou Y; Washbrook J; Sinclair A; Fish B; Francis R; Titchener-Hooker NJ; Farid SS
Biotechnol Prog; 2005; 21(4):1231-42. PubMed ID: 16080707
[TBL] [Abstract][Full Text] [Related]
20. Indian companies to watch in 2007.
Biotechnol J; 2007 Mar; 2(3):293. PubMed ID: 17354216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
